Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Heparin inhaled - Ockham Biotech

Next Previous
Search
Drug Profile

Heparin inhaled - Ockham Biotech

Alternative Names: Inhaled heparin - Ockham Biotech

Latest Information Update: 07 Jan 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ockham Biotech
  • Class Anti-infectives; Anti-inflammatories; Antithrombotics; Bronchodilators; Heparins; Mucolytics
  • Mechanism of Action Deoxyribonuclease I stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cystic fibrosis
  • New Molecular Entity No
  • Available For Licensing Yes - Asthma; Bronchiectasis; Chronic obstructive pulmonary disease; Cystic fibrosis

Highest Development Phases

  • Discontinued Chronic obstructive pulmonary disease; Cystic fibrosis

Most Recent Events

  • 26 Sep 2019 Discontinued - Phase-II for Chronic obstructive pulmonary disease in Italy (Inhalation)
  • 26 Sep 2019 Discontinued - Phase-II for Cystic fibrosis in United Kingdom (Inhalation)
  • 01 Mar 2016 Efficacy and adverse event data from a phase II trial in Chronic obstructive pulmonary disease released by Ockham Biotech

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top